News
Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...
Novo Nordisk is to launch “connected” insulin pens, responding for demands from ... AstraZeneca and Ionis add an EU green light to earlier approvals in the US and UK for ATTR polyneuropathy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback